LOTUS EYE HOSP & INST L (LOTUSEYE) financials

LOTUS EYE HOSP & INST L (LOTUSEYE) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 1990, Lotus Eye Hospitaland Institute Ltd provides ophthalmology and other related services.[1]

Market Cap: ₹237Cr.
Current Price: ₹112
Stock P/E: 1,480
ROE: 0.13%
ROCE: 1.41%
Book Value: ₹28.9
Dividend Yield: 0.00%
52W High / Low: ₹153/97.6

In Jun 2026, LOTUS EYE HOSP & INST L (LOTUSEYE) reported sales ₹17.06 Cr and net profit ₹0.61 Cr.

Annual TTM: sales ₹57.26 Cr, net profit ₹0.15 Cr.

Shareholding: Promoters 40.14% (Sep 2026), FIIs 0.00% (Sep 2026), DIIs 0.02% (Sep 2026), Public 59.85% (Sep 2026), No. of Shareholders 9,572% (Sep 2026).

LOTUSEYE quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	12.91	12.25	11.51	13.52	13.04	13.55	13.61	17.06
Expenses	11.76	11.46	11.68	12.04	12.27	12.89	13.13	14.11
Operating Profit	1.15	0.79	-0.17	1.48	0.77	0.66	0.48	2.95
OPM %	8.91%	6.45%	-1.48%	10.95%	5.90%	4.87%	3.53%	17.29%
Other Income	0.27	0.22	0.52	0.19	0.27	0.24	0.47	0.21
Interest	0.08	0.13	0.09	0.12	0.12	0.29	0.33	0.51
Depreciation	1.23	1.31	-0.58	0.82	0.85	0.98	1.10	1.64
Profit before tax	0.11	-0.43	0.84	0.73	0.07	-0.37	-0.48	1.01
Tax %	9.09%	-44.19%	70.24%	24.66%	-71.43%	-29.73%	-33.33%	39.60%
Net Profit	0.10	-0.24	0.25	0.54	0.12	-0.26	-0.32	0.61
EPS in Rs	0.05	-0.12	0.12	0.26	0.06	-0.13	-0.15	0.29
Raw PDF	—	—	—	—	—	—	—	—

LOTUSEYE profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	40.55	32.35	38.90	47.03	48.20	49.55	53.70	57.26
Expenses	36.57	28.73	32.98	39.35	41.57	45.99	50.15	52.40
Operating Profit	3.98	3.62	5.92	7.68	6.63	3.56	3.55	4.86
OPM %	9.82%	11.19%	15.22%	16.33%	13.76%	7.18%	6.61%	8.49%
Other Income	0.21	0.84	0.88	1.15	1.31	1.31	1.18	1.19
Interest	0.24	0.14	0.21	0.20	0.20	0.48	1.03	1.25
Depreciation	2.50	2.33	2.50	2.98	3.73	3.01	3.75	4.57
Profit before tax	1.45	1.99	4.09	5.65	4.01	1.38	-0.05	0.23
Tax %	26.90%	21.11%	27.14%	27.79%	27.43%	46.38%	-280.00%	—
Net Profit	1.06	1.57	2.98	4.08	2.91	0.74	0.08	0.15
EPS in Rs	0.51	0.75	1.43	1.96	1.40	0.36	0.04	0.07
Dividend Payout %	0.00%	66.24%	34.90%	25.49%	0.00%	0.00%	0.00%	—

LOTUSEYE balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	20.80	20.80	20.80	20.80	20.80	20.80	20.80	20.80
Reserves	29.32	30.46	31.90	33.81	36.78	38.61	39.20	39.34
Borrowings	0.22	0.32	0.40	1.24	0.67	1.11	3.43	15.83
Other Liabilities	6.18	6.53	6.12	5.75	4.93	6.11	6.14	6.63
Total Liabilities	56.52	58.11	59.22	61.60	63.18	66.63	69.57	82.60
Fixed Assets	44.14	42.67	40.54	44.07	44.18	48.65	54.07	65.81
CWIP	0.29	0.00	0.00	0.00	0.00	0.08	0.00	0.09
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	12.09	15.44	18.68	17.53	19.00	17.90	15.50	16.70
Total Assets	56.52	58.11	59.22	61.60	63.18	66.63	69.57	82.60

LOTUSEYE cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	4.20	4.97	2.73	4.41	4.39	5.68	2.70	3.02
Cash from Investing Activity	-4.01	-0.68	0.49	-3.94	-2.19	-4.63	-6.13	-14.39
Cash from Financing Activity	-1.41	0.13	-0.32	-1.58	-1.71	-3.40	-1.60	9.03
Net Cash Flow	-1.22	4.42	2.90	-1.10	0.49	-2.35	-5.03	-2.34
Free Cash Flow	-0.49	3.54	2.61	-0.25	1.30	0.10	-2.09	-10.01
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	134%	132%	84%	89%	76%	101%	94%	94%

LOTUSEYE shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	40.14%	40.22%	40.39%	40.63%	40.66%	40.14%	40.14%	40.14%
FIIs	0.00%	0.00%	0.01%	0.00%	0.01%	0.00%	0.00%	0.00%
DIIs	0.04%	0.04%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%
Public	59.82%	59.73%	59.57%	59.33%	59.31%	59.85%	59.85%	59.85%
No. of Shareholders	11,734	11,508	11,121	10,777	10,240	9,939	9,627	9,572

LOTUSEYE key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	7.22	5.94	8.35	5.82	9.08	9.54	9.72	8.22
Inventory Days	128.20	124.42	138.82	150.03	153.60	170.30	193.62	172.16
Days Payable	167.37	170.41	220.72	231.21	173.42	183.56	169.86	146.09
Cash Conversion Cycle	-31.95	-40.05	-73.54	-75.37	-10.74	-3.72	33.48	34.30
Working Capital Days	-15.39	-21.33	-23.92	-16.33	8.61	5.68	0.00	-12.17
ROCE %	1.66%	4.67%	3.92%	7.91%	10.25%	7.07%	2.99%	1.41%

LOTUSEYEUpdated 15 Oct 2026, 17:49

Lotus Eye Hosp & Inst L

LOTUSEYEUpdated 15 Oct 2026, 17:49

Market Cap

₹237Cr.

Current Price

₹112

High / Low

₹153/97.6

Stock P/E

1,480

ROE0.13%

ROCE1.41%

Book Value₹28.9

Face Value₹10.0

Dividend Yield0.00%

About

Incorporated in 1990, Lotus Eye Hospitaland Institute Ltd provides ophthalmology and other related services.[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	12.57	0.02	10.18	0.29	0.73	1.93	27.98	1.38	0.66
Sep 2023	12.73	0.01	10.92	0.28	0.89	1.19	28.57	0.85	0.41
Dec 2023	12.03	0.04	10.45	0.34	0.98	0.9	26.67	0.66	0.32
Mar 2024	10.88	0.03	10.12	0.4	1.12	0.01	-200	0.02	0.01
Jun 2024	12.89	0.06	11.23	0.31	1.06	0.85	28.24	0.62	0.3
Sep 2024	12.91	0.08	11.76	0.27	1.23	0.11	9.09	0.1	0.05
Dec 2024	12.25	0.13	11.46	0.22	1.31	-0.43	-44.19	-0.24	-0.12
Mar 2025	11.51	0.09	11.68	0.52	-0.58	0.84	70.24	0.25	0.12
Jun 2025	13.52	0.12	12.04	0.19	0.82	0.73	24.66	0.54	0.26
Sep 2025	13.04	0.12	12.27	0.27	0.85	0.07	-71.43	0.12	0.06
Dec 2025	13.55	0.29	12.89	0.24	0.98	-0.37	-29.73	-0.26	-0.13
Mar 2026	13.61	0.33	13.13	0.47	1.1	-0.48	-33.33	-0.32	-0.15
Jun 2026	17.06	0.51	14.11	0.21	1.64	1.01	39.6	0.61	0.29

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	29.9	0.1	27.72	0.46	4.76	-2.22	-10.81	-1.98	-0.95
Mar 2016	31.13	0.16	27.14	0.58	4.44	-0.03	-400	0.1	0.05
Mar 2017	33.96	0.15	30.63	0.68	3.44	0.42	-7.14	0.44	0.21
Mar 2018	38.02	0.18	33.68	0.91	3.37	1.7	-2.35	1.75	0.84
Mar 2019	38.43	0.21	35.21	0.68	3.06	0.63	-12.7	0.71	0.34
Mar 2020	40.55	0.24	36.57	0.21	2.5	1.45	26.9	1.06	0.51
Mar 2021	32.35	0.14	28.73	0.84	2.33	1.99	21.11	1.57	0.75
Mar 2022	38.9	0.21	32.98	0.88	2.5	4.09	27.14	2.98	1.43
Mar 2023	47.03	0.2	39.35	1.15	2.98	5.65	27.79	4.08	1.96
Mar 2024	48.2	0.2	41.57	1.31	3.73	4.01	27.43	2.91	1.4
Mar 2025	49.55	0.48	45.99	1.31	3.01	1.38	46.38	0.74	0.36
Mar 2026	53.7	1.03	50.15	1.18	3.75	-0.05	-280	0.08	0.04
TTM	57.26	1.25	52.4	1.19	4.57	0.23	—	0.15	0.07

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	40.14%
DIIs	0.02%
Public	59.85%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2023	56.58%	0%	0%	43.42%
Mar 2024	41.4%	0%	0%	58.6%
Jun 2024	40.24%	0%	0%	59.76%
Sep 2024	40.03%	0%	0%	59.97%
Dec 2024	40.14%	0%	0.04%	59.82%
Mar 2025	40.22%	0%	0.04%	59.73%
Jun 2025	40.39%	0.01%	0.02%	59.57%
Sep 2025	40.63%	0%	0.02%	59.33%
Dec 2025	40.66%	0.01%	0.02%	59.31%
Mar 2026	40.14%	0%	0.02%	59.85%
Jun 2026	40.14%	0%	0.02%	59.85%
Sep 2026	40.14%	0%	0.02%	59.85%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Other Assets	Total Assets
Mar 2015	20.8	28.59	0.83	6.2	56.42	47.04	0.27	9.11	56.42
Mar 2016	20.8	28.69	0.66	4.68	54.83	43.57	0.42	10.84	54.83
Mar 2017	20.8	29.26	0.48	4.4	54.94	41.32	0.65	12.97	54.94
Mar 2018	20.8	29.84	0.29	7.28	58.21	42.52	0.29	15.4	58.21
Mar 2019	20.8	29.32	0.22	6.18	56.52	44.14	0.29	12.09	56.52
Mar 2020	20.8	30.46	0.32	6.53	58.11	42.67	0	15.44	58.11
Mar 2021	20.8	31.9	0.4	6.12	59.22	40.54	0	18.68	59.22
Mar 2022	20.8	33.81	1.24	5.75	61.6	44.07	0	17.53	61.6
Mar 2023	20.8	36.78	0.67	4.93	63.18	44.18	0	19	63.18
Mar 2024	20.8	38.61	1.11	6.11	66.63	48.65	0.08	17.9	66.63
Mar 2025	20.8	39.2	3.43	6.14	69.57	54.07	0	15.5	69.57
Mar 2026	20.8	39.34	15.83	6.63	82.6	65.81	0.09	16.7	82.6

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	2.37	-4.65	1.87	-0.4
Mar 2016	3.38	-0.85	-0.58	1.96
Mar 2017	2.97	-1.06	-0.25	1.66
Mar 2018	5.78	-3.86	-1.51	0.41
Mar 2019	4.2	-4.01	-1.41	-1.22
Mar 2020	4.97	-0.68	0.13	4.42
Mar 2021	2.73	0.49	-0.32	2.9
Mar 2022	4.41	-3.94	-1.58	-1.1
Mar 2023	4.39	-2.19	-1.71	0.49
Mar 2024	5.68	-4.63	-3.4	-2.35
Mar 2025	2.7	-6.13	-1.6	-5.03
Mar 2026	3.02	-14.39	9.03	-2.34

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	4.27	5.98	7.31	10.94	7.22	5.94	8.35	5.82	9.08	9.54	9.72	8.22
Inventory Days	121.54	113.25	60.22	79.23	128.20	124.42	138.82	150.03	153.60	170.30	193.62	172.16
Days Payable	125.08	105.51	87.32	129.95	167.37	170.41	220.72	231.21	173.42	183.56	169.86	146.09
Cash Conversion Cycle	0.73	13.72	-19.79	-39.78	-31.95	-40.05	-73.54	-75.37	-10.74	-3.72	33.48	34.30
Working Capital Days	-19.90	-8.56	-8.92	-26.02	-15.39	-21.33	-23.92	-16.33	8.61	5.68	0.00	-12.17
ROCE %	-4.23%	0.24%	1.19%	3.63%	1.66%	4.67%	3.92%	7.91%	10.25%	7.07%	2.99%	1.41%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of LOTUS EYE HOSP & INST L (LOTUSEYE)?

The reported market capitalisation for LOTUS EYE HOSP & INST L (LOTUSEYE) is ₹237Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of LOTUSEYE?

The current price shown for LOTUS EYE HOSP & INST L (LOTUSEYE) on Fincrux is ₹112 with a 52-week high/low of ₹153/97.6.

What is the P/E ratio of LOTUS EYE HOSP & INST L (LOTUSEYE)?

The stock P/E for LOTUS EYE HOSP & INST L (LOTUSEYE) is 1,480 on Fincrux, with ROE at 0.13% and ROCE at 1.41%.

What were LOTUSEYE latest quarterly results?

For Jun 2026, LOTUS EYE HOSP & INST L (LOTUSEYE) reported sales ₹17.06 Cr and net profit ₹0.61 Cr (figures in ₹ crore unless noted).

What are LOTUSEYE annual sales and net profit?

For TTM, LOTUS EYE HOSP & INST L (LOTUSEYE) shows sales of ₹57.26 Cr and net profit of ₹0.15 Cr on the Fincrux profit & loss statement.

Who owns LOTUS EYE HOSP & INST L (LOTUSEYE)?

Latest shareholding for LOTUS EYE HOSP & INST L (LOTUSEYE) on Fincrux: Promoters 40.14% (Sep 2026), FIIs 0.00% (Sep 2026), DIIs 0.02% (Sep 2026), Public 59.85% (Sep 2026), No. of Shareholders 9,572% (Sep 2026).

Where can I find LOTUS EYE HOSP & INST L (LOTUSEYE) financials?

LOTUS EYE HOSP & INST L (LOTUSEYE) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show LOTUSEYE balance sheet and cash flow?

Yes. The LOTUS EYE HOSP & INST L (LOTUSEYE) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 15 October 2026 at 17:49